13-19935063-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The XM_047430584.1(ZMYM2):​c.-163-15828A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 151,846 control chromosomes in the GnomAD database, including 14,386 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 14386 hom., cov: 32)

Consequence

ZMYM2
XM_047430584.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.01

Publications

3 publications found
Variant links:
Genes affected
ZMYM2 (HGNC:12989): (zinc finger MYM-type containing 2) The protein encoded by this gene is a zinc finger protein that may act as a transcription factor. The encoded protein may be part of a BHC histone deacetylase complex. Translocation of this gene with the fibroblast growth factor receptor-1 gene (FGFR1) results in a fusion gene, which may be a cause of stem cell leukemia lymphoma syndrome (SCLL). Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
ZMYM2 Gene-Disease associations (from GenCC):
  • neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • congenital anomaly of kidney and urinary tract
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Franklin by Genoox

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.

Variant Effect in Transcripts

 

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Frequencies

GnomAD3 genomes
AF:
0.433
AC:
65724
AN:
151728
Hom.:
14377
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.506
Gnomad AMI
AF:
0.296
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.524
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.425
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.395
Gnomad OTH
AF:
0.426
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.433
AC:
65749
AN:
151846
Hom.:
14386
Cov.:
32
AF XY:
0.431
AC XY:
31982
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.506
AC:
20949
AN:
41412
American (AMR)
AF:
0.448
AC:
6822
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.524
AC:
1819
AN:
3470
East Asian (EAS)
AF:
0.400
AC:
2060
AN:
5148
South Asian (SAS)
AF:
0.315
AC:
1518
AN:
4818
European-Finnish (FIN)
AF:
0.425
AC:
4468
AN:
10516
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.395
AC:
26836
AN:
67930
Other (OTH)
AF:
0.423
AC:
893
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1856
3712
5568
7424
9280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.409
Hom.:
23424
Bravo
AF:
0.442
Asia WGS
AF:
0.355
AC:
1238
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.5
DANN
Benign
0.51
PhyloP100
-1.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7320671; hg19: chr13-20509203; API